ADLAI NORTYE GROUP LTD

Adlai Nortye Ltd. shares surged 5.83 % in a 24‑hour trade, reaching $10.49 amid biotech buzz—learn why the market’s eye on this cancer‑therapy firm.

Adlai Nortye’s shares surge 5.83% in 24h, now $10.87, as biotech eyes new cancer therapies and market‑cap hits $719.6 M.

Adlai Nortye (ANL) shares climb 2.5%, hinting at a short‑term rebound amid a 31% monthly drop—investors watch biotech pipeline and regulatory news.